$572 Million is the total value of Iron Triangle Partners LP's 27 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 64.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRL | New | CHARLES RIV LABS INTL INC | $39,754,000 | – | 202,000 | +100.0% | 6.95% | – |
| CI | Buy | CIGNA CORP NEW | $39,681,000 | +88.2% | 143,010 | +78.8% | 6.94% | +153.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $37,768,000 | +10.7% | 355,601 | +1.6% | 6.60% | +49.3% |
| SNY | New | SANOFIsponsored adr | $34,218,000 | – | 900,000 | +100.0% | 5.98% | – |
| HQY | Sell | HEALTHEQUITY INC | $29,555,000 | -0.8% | 440,000 | -9.4% | 5.17% | +33.7% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $27,363,000 | -26.4% | 350,000 | -36.4% | 4.78% | -0.8% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $27,111,000 | -27.3% | 700,000 | -30.0% | 4.74% | -1.9% |
| GH | Sell | GUARDANT HEALTH INC | $26,226,000 | -34.4% | 487,193 | -50.8% | 4.58% | -11.5% |
| HCA | New | HCA HEALTHCARE INC | $25,731,000 | – | 140,000 | +100.0% | 4.50% | – |
| NARI | New | INARI MED INC | $21,792,000 | – | 300,000 | +100.0% | 3.81% | – |
| BIO | Sell | BIO RAD LABS INCcl a | $20,857,000 | -27.3% | 50,000 | -13.7% | 3.65% | -2.0% |
| RGEN | Sell | REPLIGEN CORP | $18,711,000 | -53.9% | 100,000 | -60.0% | 3.27% | -37.9% |
| PODD | New | INSULET CORP | $18,352,000 | – | 80,000 | +100.0% | 3.21% | – |
| CTLT | New | CATALENT INC | $18,090,000 | – | 250,000 | +100.0% | 3.16% | – |
| INSP | Sell | INSPIRE MED SYS INC | $17,737,000 | -14.8% | 100,000 | -12.2% | 3.10% | +14.9% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $17,600,000 | -0.4% | 322,278 | -0.8% | 3.08% | +34.2% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $17,415,000 | – | 3,000,000 | +100.0% | 3.04% | – |
| HUM | Sell | HUMANA INC | $16,982,000 | -63.7% | 35,000 | -65.0% | 2.97% | -51.1% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $16,581,000 | – | 150,000 | +100.0% | 2.90% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $16,406,000 | +37.1% | 265,076 | +76.7% | 2.87% | +84.9% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $16,013,000 | – | 80,000 | +100.0% | 2.80% | – |
| ICLR | Sell | ICON PLC | $15,400,000 | -55.6% | 83,798 | -47.6% | 2.69% | -40.1% |
| MASS | Buy | 908 DEVICES INC | $14,805,000 | -15.4% | 900,000 | +5.9% | 2.59% | +14.0% |
| SGRY | Buy | SURGERY PARTNERS INC | $12,870,000 | +65.9% | 550,000 | +105.1% | 2.25% | +123.7% |
| DXCM | Sell | DEXCOM INC | $12,081,000 | -67.6% | 150,000 | -70.0% | 2.11% | -56.3% |
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $9,865,000 | +0.6% | 999,513 | 0.0% | 1.72% | +35.7% | |
| STXS | Sell | STEREOTAXIS INC | $3,054,000 | -2.7% | 1,696,599 | -0.6% | 0.53% | +31.2% |
| Exit | SOMALOGIC INC | $0 | – | -1,000,000 | -100.0% | -0.59% | – | |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -1,100,000 | -100.0% | -0.64% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -260,000 | -100.0% | -3.23% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -495,329 | -100.0% | -3.53% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -437,477 | -100.0% | -3.75% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -350,000 | -100.0% | -6.95% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -400,000 | -100.0% | -19.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.